Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2023 11:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Hepatic Encephalopathy Treatment Market is expected to reach value of US$ 2971.51 Million by registering a CAGR of 6.5% through 2033 | Future Market Insights, Inc.

NEWARK, Del, March 20, 2023 (GLOBE NEWSWIRE) -- During the forecast period 2023 to 2033, the Hepatic Encephalopathy Treatment Market is expected to grow at a value of 6.5% CAGR, according to Future...
March 01, 2016 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)

SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
February 18, 2016 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Receives Publication Through American Chemical Society for KLS-13019, a Novel Cannabidiol-Derived Target Drug Candidate for Hepatic Encephalopathy

SAN DIEGO, Feb. 18, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
August 14, 2015 09:00 ET | Source: Medical Marijuana Inc

Medical Marijuana, Inc's Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

SAN DIEGO, Aug. 14, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2...
August 06, 2015 13:54 ET | Source: KannaLife Sciences, Inc.

KannaLife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- KannaLife Sciences, Inc., a Phyto-Medical Company, announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized...
June 23, 2015 13:55 ET | Source: Medical Marijuana Inc

Photo Release -- Medical Marijuana, Inc.'s HempMeds & Investment Company KannaLife Sciences Gain Global News Attention at New York Cannabis Convention

SAN DIEGO, June 23, 2015 (GLOBE NEWSWIRE) -- As New York prepares for access to medical cannabis, many entrepreneurs curious about establishing businesses in support of the historic statewide...